New directions in the systemic treatment of metastatic thyroid cancer

A Forastiere, S Marur - Oncology, 2009 - search.proquest.com
Medical oncologists have traditionally had little to offer patients with metastatic radioactive
iodine-resistant thyroid cancer. The 3-year survival rate of patients with differentiated thyroid …
被引用次数：22 相关文章

New directions in the systemic treatment of metastatic thyroid cancer.

MJ Higgins, A Forastiere, S Marur - Oncology (Williston Park, NY), 2009 - europepmc.org
A comment on this article appears in" Radioiodine-resistant differentiated thyroid cancer:
hope for the future." Oncology (Williston Park). 2009 Aug; 23 (9): 775-6. A comment on this …

New directions in the systemic treatment of metastatic thyroid cancer

MJ Higgins, A Forastiere, S Marur - Oncology, 2009 - hero.epa.gov
Medical oncologists have traditionally had little to offer patients with metastatic radioactive
iodine-resistant thyroid cancer. The 3-year survival rate of patients with differentiated thyroid …

New directions in the systemic treatment of metastatic thyroid cancer

MJ Higgins, A Forastiere, S Marur - Oncology, 2009 - go.gale.com
Medical oncologists have traditionally had little to offer patients with metastatic radioactive
iodine-resistant thyroid cancer. The 3-year survival rate of patients with differentiated thyroid …

New directions in the systemic treatment of metastatic thyroid cancer

MJ Higgins, A Forastiere, S Marur - ONCOLOGY, 2009 - pure.johnshopkins.edu
Medical oncologists have traditionally had little to offer patients with metastatic radioactive
iodineresistant thyroid cancer. The 3-year survival rate of patients with differentiated thyroid …

New directions in the systemic treatment of metastatic thyroid cancer

MJ Higgins, A Forastiere… - … (Williston Park, NY), 2009 - pubmed.ncbi.nlm.nih.gov
Medical oncologists have traditionally had little to offer patients with metastatic radioactive
iodine-resistant thyroid cancer. The 3-year survival rate of patients with differentiated thyroid …